BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:49 PM
 | 
May 21, 2010
 |  BC Extra  |  Clinical News

Amgen releases ASCO abstracts

Amgen Inc. (NASDAQ:AMGN) announced the availability of abstracts slated for presentation at the American Society of Clinical Oncology meeting in Chicago in June, including abstracts for the first presentations of Phase II data for AMG 479 in pancreatic cancer and AMG 386 in ovarian cancer. Data from a double-blind Phase II study in 125 patients with metastatic pancreatic cancer showed that gemcitabine in combination with...

Read the full 320 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >